X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (33) 33
index medicus (32) 32
female (25) 25
article (21) 21
oncology (18) 18
male (15) 15
aged (13) 13
investigating or analysing materials by determining theirchemical or physical properties (13) 13
measuring (13) 13
physics (13) 13
testing (13) 13
cancer (12) 12
middle aged (12) 12
lung neoplasms - pathology (11) 11
prognosis (11) 11
lung cancer (10) 10
mutation (10) 10
biochemistry (9) 9
carcinoma, non-small-cell lung - pathology (9) 9
chemistry (9) 9
immunohistochemistry (9) 9
metallurgy (9) 9
microbiology (9) 9
protein expression (9) 9
survival (9) 9
adult (8) 8
beer (8) 8
carcinoma (8) 8
compositions or test papers therefor (8) 8
condition-responsive control in microbiological orenzymological processes (8) 8
enzymology (8) 8
measuring or testing processes involving enzymes, nucleicacids or microorganisms (8) 8
medicine, research & experimental (8) 8
mutation or genetic engineering (8) 8
pathology (8) 8
processes of preparing such compositions (8) 8
spirits (8) 8
vinegar (8) 8
wine (8) 8
aged, 80 and over (7) 7
biomarkers (7) 7
cohort studies (7) 7
peptides (7) 7
abridged index medicus (6) 6
estrogen-receptor (6) 6
genomics (6) 6
lung neoplasms - metabolism (6) 6
neoplasm staging (6) 6
research (6) 6
tissue array analysis (6) 6
treatment outcome (6) 6
tumors (6) 6
adenocarcinoma - pathology (5) 5
animals (5) 5
breast neoplasms - metabolism (5) 5
breast-cancer (5) 5
carcinoma, non-small-cell lung - metabolism (5) 5
cell biology (5) 5
cell line, tumor (5) 5
lung cancer, non-small cell (5) 5
multidisciplinary sciences (5) 5
organic chemistry (5) 5
adenocarcinoma (4) 4
analysis (4) 4
antineoplastic agents - therapeutic use (4) 4
apoptosis (4) 4
biomarkers, tumor - metabolism (4) 4
cancer therapies (4) 4
carcinoma, non-small-cell lung - genetics (4) 4
care and treatment (4) 4
chemotherapy (4) 4
expression (4) 4
fluorescent antibody technique (4) 4
genetic aspects (4) 4
growth-factor receptor (4) 4
health aspects (4) 4
human necessities (4) 4
hygiene (4) 4
immunotherapy (4) 4
lung neoplasms - genetics (4) 4
lymphocytes (4) 4
medical or veterinary science (4) 4
medical research (4) 4
multivariate analysis (4) 4
neoplasms. tumors. oncology. including cancer and carcinogens (4) 4
pd-1 blockade (4) 4
preparations for medical, dental, or toilet purposes (4) 4
proteins (4) 4
reproducibility of results (4) 4
therapy (4) 4
time factors (4) 4
usage (4) 4
algorithms (3) 3
amplification (3) 3
antigens (3) 3
antineoplastic agents - pharmacology (3) 3
biological markers (3) 3
biomarkers, tumor - analysis (3) 3
blotting, western (3) 3
breast (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 21, pp. 1976 - 1986
Journal Article
Nature, ISSN 0028-0836, 10/2015, Volume 526, Issue 7572, pp. 263 - 267
Colorectal cancer is the third most common cancer worldwide, with 1.2 million patients diagnosed annually. In late-stage colorectal cancer, the most commonly... 
PANITUMUMAB | THERAPY | MULTIDISCIPLINARY SCIENCES | SEQUENCE | ACQUIRED-RESISTANCE | SOMATIC MUTATION | IDENTIFICATION | GENE COPY NUMBER | ACTIVATING MUTATIONS | BREAST | INSIGHTS | Receptor, Epidermal Growth Factor - genetics | Receptor, ErbB-2 - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Genomics | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Molecular Targeted Therapy | Receptor, Fibroblast Growth Factor, Type 1 - genetics | MAP Kinase Kinase 1 - genetics | Colorectal Neoplasms - drug therapy | Female | Antineoplastic Agents - pharmacology | Insulin Receptor Substrate Proteins - genetics | Colorectal Neoplasms - metabolism | Antibodies, Monoclonal - pharmacology | Cetuximab - pharmacology | DNA Copy Number Variations - genetics | Mutation - genetics | Genome, Human - genetics | Receptor, Epidermal Growth Factor - chemistry | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Exome - genetics | Animals | Receptor, Platelet-Derived Growth Factor alpha - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Drug Resistance, Neoplasm - drug effects | Care and treatment | Gene mutations | Colorectal cancer | Drug metabolism | Genetic aspects | Identification and classification | Health aspects | Proteins | Epidermal growth factor | Genes | Clinical trials | Mutation | Kinases | Cancer therapies | Tumors
Journal Article
BMC Cancer, ISSN 1471-2407, 05/2010, Volume 10, Issue 1, pp. 186 - 186
Background: Bcl-2 promotes cell survival by inhibiting adapters needed for the activation and cleavage of caspases thus blocking the proteolytic cascade that... 
APOPTOSIS-RELATED PROTEINS | SURVIVAL | ONCOLOGY | SUBCELLULAR-LOCALIZATION | ANTISENSE OLIGONUCLEOTIDE | DEATH | FAMILY PROTEINS | LYMPHOID-CELLS | PROGNOSTIC VALUE | CARCINOMA | P53 | Predictive Value of Tests | Up-Regulation | Adenocarcinoma - pathology | Carcinoma, Non-Small-Cell Lung - chemistry | Lung Neoplasms - mortality | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Greece | Carcinoma, Squamous Cell - mortality | Time Factors | Proto-Oncogene Proteins c-bcl-2 - analysis | Female | Cell Differentiation | Retrospective Studies | Adenocarcinoma - chemistry | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Large Cell - chemistry | Reproducibility of Results | Lung Neoplasms - chemistry | Risk Assessment | Biomarkers, Tumor - analysis | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Carcinoma, Squamous Cell - chemistry | Treatment Outcome | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Connecticut | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Cohort Studies | Care and treatment | Usage | Lung cancer | Patient outcomes | Development and progression | Histology | Research | Gene expression | Quantitative genetics | Cohort analysis | Physiological aspects | Methods | Cancer
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2017, Volume 23, Issue 17, pp. 4959 - 4969
Journal Article
Journal Article
Journal Article
In Vivo, ISSN 0258-851X, 11/2008, Volume 22, Issue 6, p. 886
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2012, Volume 7, Issue 2, p. e31331
Introduction: We assessed expression of p85 and p110 alpha PI3K subunits in non-small cell lung cancer (NSCLC) specimens and the association with mTOR... 
ONCOGENIC K-RAS | MAMMALIAN TARGET | GROWTH-FACTOR RECEPTOR | APOPTOSIS | BRONCHIAL EPITHELIAL-CELLS | P85 REGULATORY SUBUNIT | AKT/PROTEIN-KINASE-B | NEGATIVE REGULATION | MULTIDISCIPLINARY SCIENCES | DUAL PI3K/MTOR INHIBITOR | PHOSPHOINOSITIDE 3-KINASE | Lung Neoplasms - drug therapy | Class Ia Phosphatidylinositol 3-Kinase - metabolism | Adenocarcinoma - pathology | TOR Serine-Threonine Kinases - metabolism | Tissue Array Analysis | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - metabolism | Middle Aged | Lung Neoplasms - pathology | Male | Immunoenzyme Techniques | TOR Serine-Threonine Kinases - antagonists & inhibitors | Adenocarcinoma - metabolism | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Non-Small-Cell Lung - metabolism | Adenocarcinoma - drug therapy | Blotting, Western | Class Ia Phosphatidylinositol 3-Kinase - antagonists & inhibitors | Drug Synergism | Carcinoma, Squamous Cell - drug therapy | Signal Transduction - drug effects | Fluorescent Antibody Technique | Cell Line, Tumor | Aged | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Squamous cell carcinoma | Oncology, Experimental | Lung cancer, Small cell | Phospholipids | Research | Lung cancer, Non-small cell | Cancer | TOR protein | Biotechnology | Biomedical research | Lung cancer | Clinical trials | AKT protein | Kinases | Medical diagnosis | Autophagy | Proteins | Cell growth | Inhibition | Quantitative analysis | Medical research | Epidermal growth factor receptors | Melanoma | Non-small cell lung carcinoma | Rapamycin | Survival | 1-Phosphatidylinositol 3-kinase | Medicine | Chemotherapy | Inhibitors | Protein synthesis | Cell lines | Mutation | Apoptosis | Tumors
Journal Article